Published online before print August 29, 2002, doi: 10.1161/01.ATV.0000035405.16217.86
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2002 American Heart Association, Inc.
Thrombosis |
Increased Serum Homocysteine and Sudden Death Resulting from Coronary Atherosclerosis With Fibrous Plaques
From the Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC (R.V., A.P.B., F.K.); the Veteran’s Affairs Medical Center (L.F., V.F.), Little Rock, Ark; and Louisiana State University (A.Z.), New Orleans, La.
Correspondence to Renu Virmani, MD, Chairperson, Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC. E-mail virmani{at}afip.osd.mil
Introduction— Modest elevations of total homocysteine have been associated with increased risk for coronary atherosclerosis but correlation between elevated homocysteine and plaque morphology has not been described in humans.
Methods— We determined serum homocysteine at postmortem from 87 men with coronary thrombus (62 of whom were diagnosed as acute), from 35 men with severe coronary disease without thrombus, and from 46 controls. In coronary deaths, atherosclerotic plaques at the sites of maximal luminal narrowing of the four epicardial coronary arteries were classified as fibrous plaques, fibrous cap atheromas, thin-cap atheromas, and healed ruptures, and macrophage infiltration was assessed semiquantitatively.
Results— Median serum homocysteine postmortem as a result of acute thrombus was 10.4 µmol/L (P=0.4 versus controls), 12.1 µmol/L in men with organized thrombi (P=0.1 versus controls), 15.6 µmol/L in men without thrombus (P=0.007 versus controls), and 9.8 µmol/L in controls. The median homocysteine was 12.1 µmol/L in 65 men with healed infarcts (P=0.03 versus controls). The number of fibrous plaques was associated with log-normalized homocysteine (P=0.004), independent of age, albumin, smoking, hypertension, and serum cholesterol. Homocysteine levels in the upper tertile (>15 µmol/L) were associated with sudden death without acute or organized thrombus (odds ratio 3.8, P=0.03) independent of age and other risk factors; the coexistence of diabetes increased the association (odds ratio 25.1, P=0.009, versus lowest tertile 
8.5 µmol/L).
Conclusions— Increased serum homocysteine is associated with sudden death in the absence of acute coronary thrombosis, especially with concomitant diabetes, and with the presence of lipid-poor, fibrous plaques.
Key Words: homocysteine • diabetes • coronary artery disease • sudden death • thrombosis
This article has been cited by other articles:
 |
|
 |
|
  K. S. Moshal, S. M. Tipparaju, T. P. Vacek, M. Kumar, M. Singh, I. E. Frank, P. K. Patibandla, N. Tyagi, J. Rai, N. Metreveli, et al. Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H890 - H897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhou, G. H. Werstuck, S. Lhotak, Y. Y. Shi, V. Tedesco, B. Trigatti, J. Dickhout, A. K. Majors, P. M. DiBello, D. W. Jacobsen, et al. Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice FASEB J, July 1, 2008; 22(7): 2569 - 2578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. H. Woo, Y. L. Siow, G. N. Pierce, P. C. Choy, G. Y. Minuk, D. Mymin, and K. O Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1002 - E1010. [Abstract] [Full Text] [PDF]
|
|